MATRIX PHARMACEUTICALS ApS: Financial statements 2022
CVR: 29625867
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,166,040 and a net result of DKK 580,419 compared with DKK 776,310 the year before. The profit margin was 49.8%. Equity in the 2022 report amounted to DKK -80,419.
- Revenue
- DKK 1,166,040
- Gross Profit
- DKK 1,166,040
- Profit/Loss
- DKK 580,419
- Equity
- DKK -80,419
- Total Assets
- DKK 96,115
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 1.2 mio. | 1.2 mio. | 580 t. | -80 t. | - |
| 2021 | - | 843 t. | 776 t. | -678 t. | 1 |
| 2020 | - | 849 t. | 731 t. | -1.5 mio. | 1 |
| 2019 | - | 35 t. | -310 t. | -2.2 mio. | - |
| 2018 | -56 t. EUR | - | -638 t. EUR | -1.9 mio. EUR | - |
Official annual report
Keep an eye on MATRIX PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MATRIX PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 842,995, and the net result was DKK 776,310.
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.